PAPER Dunham I, Shimizu N, Roe BA, Chissoe S, Hunt AR, Collins JE, Bruskiewich R, Beare DM, Clamp M, Smink LJ, Ainscough R, Almeida JP, Babbage A, Bagguley C, Bailey J, Barlow K, Bates KN, Beasley O, Bird CP, Blakey S, Bridgeman AM, Buck D, Burgess J, Burrill WD, O'Brien KP

The DNA sequence of human chromosome 22.

Nature. 1999 Dec 2;402(6761):489-95. PubMed: 10591208

Imaging in Drug Discovery Conference 2014

CONFERENCE 2014-10-07 00:00:00-2014-10-08 00:00:00 Dublin, Ireland 07 October 2014 to 08 October 2014 This meeting seeks to provide a forum for researchers from both industry and academia to share about the latest advances in imaging applications in drug safety and metabolism, cancer immunotherapy, neurod

PAPER Yan JQ, Yuan YH, Gao YN, Huang JY, Ma KL, Gao Y, Zhang WQ, Guo XF, Chen NH

Erratum to: Overexpression of Human E46K Mutant α-Synuclein Impairs Macroautophagy via Inactivation of JNK1-Bcl-2 Pathway.

Mol Neurobiol. 2014 Oct;50(2):702-3. PubMed: 24880752

PAPER Vijayalakshmi K, Ostwal P, Sumitha R, Shruthi S, Varghese AM, Mishra P, Manohari SG, Sagar BC, Sathyaprabha TN, Nalini A, Raju TR, Alladi PA

Role of VEGF and VEGFR2 Receptor in Reversal of ALS-CSF Induced Degeneration of NSC-34 Motor Neuron Cell Line.

Mol Neurobiol. 2014 Jun 1; PubMed: 24880751

PAPER Lancioni GE, Singh NN, O'Reilly MF, Sigafoos J, Renna C, Pinto K, De Vanna F, Caffò AO, Stasolla F

Persons with moderate Alzheimer's disease use simple technology aids to manage daily activities and leisure occupation.

Res Dev Disabil. 2014 Sep;35(9):2117-28. Epub 2014 May 28 PubMed: 24881006

PAPER Sassi C, Guerreiro R, Gibbs R, Ding J, Lupton MK, Troakes C, Lunnon K, Al-Sarraj S, Brown KS, Medway C, Lord J, Turton J, Mann D, Snowden J, Neary D, Harris J, Bras J, ARUK Consortium, Morgan K, Powell JF, Singleton A, Hardy J

Exome sequencing identifies 2 novel presenilin 1 mutations (p.L166V and p.S230R) in British early-onset Alzheimer's disease.

Neurobiol Aging. 2014 Oct;35(10):2422.e13-6. Epub 2014 May 2 PubMed: 24880964

PAPER Quintana Hernández DJ, Miró Barrachina MT, Ibáñez Fernández I, del Pino AS, García Rodríguez Jr, Hernández JR

[Effects of a neuropsychology program based on mindfulness on Alzheimer's disease: randomized double-blind clinical study].

Rev Esp Geriatr Gerontol. 2014 Jul-Aug;49(4):165-72. Epub 2014 May 28 PubMed: 24880524

PAPER Udomprasert A, Bongiovanni MN, Sha R, Sherman WB, Wang T, Arora PS, Canary JW, Gras SL, Seeman NC

Amyloid fibrils nucleated and organized by DNA origami constructions.

Nat Nanotechnol. 2014 Jul;9(7):537-41. Epub 2014 Jun 1 PubMed: 24880222

Patty Carlson

Del Norte, United States

Conor McQuaid

University of Liverpool
Liverpool, United Kingdom

Jessica Ruhle

Duke University
Durham, United States

PAPER Tokuda T, Oide T, Tamaoka A, Ishii K, Matsuno S, Ikeda S

Prednisolone (30-60 mg/day) for diseases other than AD decreases amyloid beta-peptides in CSF.

Neurology. 2002 May 14;58(9):1415-8. PubMed: 12011295

PAPER Koch HJ, Szecsey A

A randomized controlled trial of prednisone in Alzheimer's disease.

Neurology. 2000 Oct 10;55(7):1067. PubMed: 11061280

PSEN2 E126K

MUTATIONS PSEN2 227073258 GRCh37/hg19 G A Exon 6 Point, Missense Coding Unknown; predicted probably damaging in silico (PHRED-scaled CADD >20). Unknown. E126K Alzheimer's Disease: Not ClassifiedAlzheimer's Disease This mutation was identified in a woma

PAPER De Strooper B, Annaert W

Proteolytic processing and cell biological functions of the amyloid precursor protein.

J Cell Sci. 2000 Jun;113 ( Pt 11):1857-70. PubMed: 10806097